New drug SLV-154 enters human testing for 10 hard-to-treat cancers
Disease control
Recruiting now
This early-phase study tests a new drug called SLV-154 in about 70 adults whose solid tumors (like head and neck, lung, breast, or ovarian cancer) have spread. The main goal is to find a safe dose and check how the body handles the drug. It is not a cure but aims to control the d…
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:59 UTC